ICP
ELV icon

Ilex Capital Partners’s Elevance Health ELV Stock Holding History

Ilex Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.9M Buy
+113,556
New +$42.1M 0.9% 36
2025
Q4 		– Sell
-1,335
Closed -$431K – 101
2025
Q3 		$431K Sell
1,335
-2,072
-61% -$644K 0.01% 109
2025
Q2 		$1.33M Sell
3,407
-4,200
-55% -$1.69M 0.04% 88
2025
Q1 		$3.31M Buy
+7,607
New +$3.05M 0.14% 45

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ilex Capital Partners's ELV Position: Q2 2026 in Review

Ilex Capital Partners opened a new position in Elevance Health (ELV) in Q2 2026: 113,556 shares worth $43.9M. The stake represents 0.9% of the portfolio and ranks #36 among its holdings. This is a return to the name: Ilex Capital Partners previously reported a position in ELV as recently as Q3 2025.

Ilex Capital Partners first reported a position in ELV in Q1 2025 and has held it in 4 quarters since. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Ilex Capital Partners held 113,556 shares of Elevance Health worth $43.9M as of Q2 2026.
  • Elevance Health was a new Ilex Capital Partners position in Q2 2026.
  • Elevance Health made up 0.9% of Ilex Capital Partners's portfolio in Q2 2026, its #36 holding.
  • Ilex Capital Partners first reported a position in Elevance Health in Q1 2025 and has held it in 4 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Ilex Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.